Order results by:
Issue | Title | |
Vol 14, No 3 (2021) | History of controlled trials in medicine: real priorities are little-known. Report 2. From early experiments to the present day: without alternation and randomization | Abstract similar documents |
A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov | ||
"... trials (CT) and randomized controlled trials (RCT), and the inclusion of these approaches in health ..." | ||
Vol 14, No 4 (2021) | History of controlled trials in medicine: real priorities are little-known. Report 3. Quasi-randomized and randomized trials in humans and animals | Abstract similar documents |
A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov | ||
"... , controlled trials (CT) and randomized controlled trials (RCT), and the inclusion of these approaches ..." | ||
Vol 14, No 1 (2021) | History of controlled trials in medicine: real priorities are little-known. Report 1. Basic concepts, terms, and disciplines that use medical experiment: historical and philosophical sources | Abstract similar documents |
A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov | ||
"... , controlled trials (CT) and randomized controlled trials (RCT), and the inclusion of these experimental ..." | ||
Vol 12, No 1 (2019) | Efficacy of photodynamic therapy in treatment of adult patients with skin cancer | Abstract similar documents |
O. V. Kirsanova | ||
"... and methods. We evaluated the data of meta-analyses, results of randomized controlled trials (RCTs ..." | ||
Vol 16, No 3 (2023) | An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis | Abstract similar documents |
M. Imawari, M. Nagase, I. Yu. Torshin, O. A. Gromova | ||
"... ® in the treatment of nonalcoholic fatty liver disease (NAFLD) in a clinical trial. Material and methods. The study ..." | ||
Vol 5, No 3 (2012) | SEARCH OF INFORMATION IN PHARMACOECONOMIC RESEARCH | Abstract similar documents |
R. I. Yagudina, I. V. Novikov, V. G. Serpik | ||
Vol 13, No 4 (2020) | Meta-analysis of clinical trials of osteoarthritis treatment effectiveness with Chondroguard | Abstract similar documents |
I. Yu. Torshin, A. M. Lila, A. V. Naumov, A. Yu. Kochish, L. I. Alekseeva, E. A. Taskina, I. V. Sarvilina, A. N. Galustyan, A. N. Gromov, A. K. Khadzhidis, L. V. Vasilieva, E. F. Yevstratova, M. I. Udovika, O. A. Gromova | ||
"... Aim. A meta-analysis of 8 controlled studies (n=771, age 53.6±6.2 years) of tie use of tie ..." | ||
Vol 8, No 2 (2015) | SYSTEMATIC LITERATURE REVIEW ON CLINICAL EFFICACY AND SAFETY OF ALOGLIPTIN IN COMPARISON WITH VILDAGLIPTIN, LINAGLIPTIN, SAXAGLIPTIN AND SITAGLIPTIN IN ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS | Abstract similar documents |
Georgii Rubenovich Khachatryan, Vladislav Sergeevich Dombrovskii | ||
"... controlled trials (RCT) EXAMINE, SAVOR-TIMI 53 and TECOS. Conclusion. There were no differences in efficacy ..." | ||
Vol 8, No 4 (2015) | CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS | Abstract similar documents |
E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva | ||
"... of randomized controlled trials (RCT) and indirect RCT comparison. The expenditures for drugs of TRA group ..." | ||
Vol 7, No 1 (2014) | ROLE OF RANDOMIZED TRIALS IN PHARMACOEPIDEMIOLOGY | Abstract similar documents |
T. L. Galankin, A. S. Kolbin | ||
"... in post-marketing drug research by the example of large simple trials. ..." | ||
Vol 18, No 1 (2025) | Trends in the industry of clinical trials | Abstract similar documents |
S. S. Milovanov, V. V. Popov, N. V. Teplova | ||
"... Background. The clinical trial (CT) industry is subject to changes, some of which are rapidly ..." | ||
Vol 15, No 1 (2022) | Efficacy of targeted drugs for the treatment of adults with moderate-to-severe plaque psoriasis in the Russian Federation: a systematic literature review update | Abstract similar documents |
V. D. Sokolova, N. A. Sableva, V. V. Mladov, D. G. Tolkacheva | ||
"... trials (RCTs) on a new interleukin (IL) 23 inhibitor registered in the Russian Federation – risankizumab ..." | ||
Vol 10, No 1 (2017) | PERAMPANEL EFFECTIVENESS IN THE TREATMENT OF REFRACTERY PARTIAL ONSET EPILEPSY WITH OR WITHOUT SECONDARY GENERALIZATION: PHARMACOECONOMIC ANALYSIS FOR THE RUSSIAN FEDERATION HEALTH CARE SYSTEM | Abstract similar documents |
N. K. Mazina, I. V. Sheshunov, P. V. Мazin, Yu. V. Kislitsin, E. M. Markova | ||
"... multicenter controlled randomized (phase III) international clinical trials in patients over 12 years of age ..." | ||
Vol 9, No 1 (2016) | PROSPECTS FOR THE USE OF METHODS OF ECONOMIC EVALUATION AT THE STAGE OF PLANNING AND ORGANISATION OF CLINICAL TRIALS | Abstract similar documents |
N. Z. Musina, V. V. Tarasov | ||
"... and organization of clinical trials and considers the examples of studies which undertook this approach. The use ..." | ||
Vol 17, No 1 (2024) | Changes in patient recruitment parameters and their derivatives under the influence of external factors – population size and density of residence in a certain area | Abstract similar documents |
S. S. Milovanov | ||
"... Background. The lack of targeted patient recruitment for clinical trials reaches 90%, which leads ..." | ||
Vol 15, No 4 (2022) | Historical milestones of the invention and use of placebo | Abstract similar documents |
A. N. Koterov | ||
"... into controlled trials, but also with the current popularity of alternative and even esoteric medicine methods ..." | ||
Vol 9, No 1 (2016) | SYSTEMATIC REVIEW OF PENTAGLOBIN EFFICACY IN PREVENTING MORTALITY IN NEWBORNS AND OLDER CHILDREN WITH BACTERIAL INFECTIONS AND SEPSIS | Abstract similar documents |
V. K. Fedyaeva, O. Yu. Rebrova | ||
"... comparison was carried out. Results. Three meta-analyses and 7RCTs were considered, including 6 trials ..." | ||
Vol 9, No 2 (2016) | PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA | Abstract similar documents |
N. A. Avxentyev, M. Yu. Frolov | ||
"... (controlled release tablets tamsulosin 0.4 mg + solifenacin 6 mg) for treatment of patients with storage ..." | ||
Vol 14, No 3 (2021) | Modern achievements in pharmacotherapy of osteoarthritis based on endo- and phenotyping | Abstract similar documents |
I. V. Sarvilina, O. A. Shavlovskaya, O. A. Gromova, A. V. Naumov, M. N. Sharov, Yu. S. Prokofyeva | ||
"... advances in pharmacotherapy of the disease based on data from selected randomized controlled trials ..." | ||
Vol 9, No 3 (2016) | EARLY HEALTH TECHNOLOGIES ASSESSMENT — NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS | Abstract similar documents |
N. Z. Musina, V. V. Omelyanovskiy, A. V. Krasheninnikova | ||
"... of the life cycle of medical technology. This method allows us to optimize the design of clinical trials ..." | ||
Vol 15, No 1 (2022) | The analysis of the consumption level of antihypertensive drugs and statins in a retail pharmacy of the Samara Region in 2015–2020 | Abstract similar documents |
I. K. Petrukhina, P. A. Lebedev, E. P. Gladunova, T. K. Ryazanova, A. A. Garanin, P. R. Blinkova | ||
"... market of the Samara Region in 2015–2020 was carried out. The material of this retrospective study ..." | ||
Vol 15, No 1 (2022) | A systematic review of real-world clinical practice data in COVID-19: non-interventional studies | Abstract similar documents |
S. A. Mishinova, Yu. M. Gomon, A. S. Kolbin, V. V. Strizheletsky, I. G. Ivanov | ||
"... designs of non-interventional real-world clinical practice trials that provide evidence for the efficacy ..." | ||
Online First | Osteoarthritis therapy misconcepts | Abstract similar documents |
O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
"... , including data on adverse events. At last, new randomized controlled trials results, new methods ..." | ||
Vol 16, No 2 (2023) | From misconceptions to reasonable osteoarthritis patients therapy | Abstract similar documents |
O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
"... , new randomized controlled trials results, new methods of adjunctive therapy become available. OA ..." | ||
Vol 15, No 2 (2022) | Current opportunities for the export of medical services in Russia | Abstract similar documents |
S. V. Russkikh, E. A. Tarasenko, S. I. Grin, M. T. Yugay, K. K. Kryukova, L. I. Moskvicheva | ||
"... with 8 high-level healthcare experts conducted in 2020. The survey was performed using the “snowball ..." | ||
Vol 16, No 2 (2023) | Analysis of social and economic aspects of using prolonged forms of opioid analgesics for the treatment of chronic pain syndrome in cancer patients | Abstract similar documents |
E. A. Pyadushkina, E. V. Derkach, A. V. Palekhov | ||
"... patients with moderate and severe CPS and a meta-analysis of randomized controlled trials, no differences ..." | ||
Vol 5, No 2 (2012) | COST EFFECTIVENESS OF ORAL PERICALCITOL IN PATIENTS WITH STAGE III-IV CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYREOSIS | Abstract similar documents |
A. V. Rudakova | ||
"... results of clinical trials demonstrate that selective vitamin D receptor agonist ..." | ||
Vol 9, No 3 (2016) | EFFICACY AND SAFETY OF THE ORAL ANTICOAGULANTS IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM: INDIRECT COMPARISON | Abstract similar documents |
V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, D. V. Frolov, E. A. Ponomarev, A. S. Maslakov | ||
"... et al. Results. The indirect comparison included 5 RCTs. Apixaban, rivaroxaban and dabigatran were ..." | ||
Vol 18, No 2 (2025) | Data analysis of medicines aimed at health technology assessment within the activities of the “Circle of Kindness” Foundation from 2021 to 2024 | Abstract similar documents |
V. V. Omelyanovskiy, A. A. Kingshott, T. S. Teptsova, P. A. Mukhortova, A. G. Kharitonova, S. I. Zinadinov, L. O. Krekhtunova, N. A. Aldushchenko, A. А. Kozak, V. A. Ryagina | ||
"... assessment was 12.00 months (interquartile range 5.52–35.94). Among study designs, randomized controlled ..." | ||
Vol 5, No 2 (2012) | METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES | Abstract similar documents |
R. I. Yagudina, I. V. Sorokovikov | ||
"... ) among studies of pharmacoeconomic analysis. Main stages of these trials are as follows: cost analysis ..." | ||
Vol 14, No 3 (2021) | Pharmacoeconomic aspects of COVID-19 treatment | Abstract similar documents |
I. V. Rogova, E. A. Zhidkova, I. A. Popova, A. V. Zaborovskiy, K. G. Gurevich | ||
"... coronavirus infection, separate groups of drugs are considered. The current clinical trials for COVID-19 ..." | ||
Vol 18, No 1 (2025) | The sale of medicines used for diabetes mellitus treatment in retail segment of Russian pharmaceutical market | Abstract similar documents |
I. K. Petrukhina, A. M. Lazarev, T. K. Ryazanova, P. A. Lebedev, E. P. Gladunova, G. T. Glembotskaya | ||
"... pharmacies in all federal districts of the RF for the period 2020–2023. In particular, the following ATС ..." | ||
Vol 15, No 3 (2022) | Funding for coronavirus health worker payments | Abstract similar documents |
I. Yu. Bocharova, A. Yu. Rymanov | ||
"... . Results. The regional distribution of transfers was regulated in 2020 by the Federal Government. The main ..." | ||
Vol 13, No 3 (2020) | The evaluation of the balance of standard rates within the program on state guarantees to deliver free medical care to the citizens of the Russian Federation | Abstract similar documents |
D. V. Fedyaev, S. A. Kovaleva, K. V. Gerasimova | ||
"... of the Government for 2019 and 2020. Materials and methods. The evaluation was performed by the methods ..." | ||
Vol 17, No 4 (2024) | The joint use of ABC/VEN analysis and the Beers criteria for optimizing expenditure of funds and rational prescribing of medications to elderly patients | Abstract similar documents |
O. A. Makhmudova, G. F. Avkhadieva, O. G. Bagdanova, V. N. Khaziakhmetova | ||
"... ; in 2020, this indicator was 10.6%; and in 2021, the costs for the procurements of drugs of N category ..." | ||
Vol 6, No 4 (2013) | Фармакоэкономический анализ использования лираглутида в составе комбинированной терапии в лечении сахарного диабета 2-го типа | Abstract similar documents |
A. Yu. Kulikov, I. V. Novikov | ||
"... with metformin, and metformin monotherapy. Methods: Data were sourced from a clinical trial comparing liraglutide ..." | ||
Vol 10, No 3 (2017) | Initiation and intensification of insulin therapy in patients with type 2 diabetes mellitus: a budget impact analysis | Abstract similar documents |
E. V. Biryukova, V. I. Ignat’eva | ||
"... the federal healthcare budget. Materials and Methods. Based on the results of the DURABLE clinical trial, we ..." | ||
Vol 14, No 3 (2021) | Pharmacoeconomic features of drug provision to the rheumatology department of the republican clinical hospital | Abstract similar documents |
L. N. Sheikhmambetova, E. A. Egorova, K. N. Onishchenko, E. I. Konyaeva | ||
"... to May 2020. Based on the obtained results, a pharmacoeconomic assessment of the budgetary funds ..." | ||
Vol 15, No 4 (2022) | Concentration of vitamin D metabolite – 25(OH)D3 as a predictor of breast cancer progression | Abstract similar documents |
D. Е. Frolova, N. P. Lapochkina, О. А. Gromova, I. Yu. Torshin | ||
"... deficiency. Material and methods. A retrospective controlled study was performed. The results of examining ..." | ||
Vol 16, No 2 (2023) | Comparative pharmacoeconomic analysis of follitropin delta application for superovulation induction during artificial insemination | Abstract similar documents |
I. S. Krysanov, V. S. Krysanova, V. Yu. Ermakova | ||
"... for controlled ovarian stimulation in adult women to induce the growth of multiple follicles during cycles ..." | ||
Vol 12, No 4 (2019) | Pharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer | Abstract similar documents |
N. A. Avxentyev, E. V. Lubennikova, M. Yu. Frolov | ||
"... for the three-year period of 2020-2022. All patients who can be treated with palbociclib or ribociclib were ..." | ||
Vol 8, No 1 (2015) | PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION | Abstract similar documents |
M. V. Avxentyeva, N. A. Avxentyev, M. Yu. Frolov, E. V. Derkach | ||
"... and efficiency were taken from D. Cibrik et al. (2013) randomized control trial. We also estimated the budget ..." | ||
Vol 18, No 1 (2025) | Problems of using phenol (hydroxybenzene) and parabens as pharmaceutical stabilizers: analysis using machine learning methods | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova | ||
"... underline the need to conduct large-scale clinical trials on the long-term toxic effects of phenol ..." | ||
Vol 15, No 2 (2022) | Strengthening medical rehabilitation services in health system: a situation analysis | Abstract similar documents |
D. V. Blinov, A. G. Solopova, L. N. Sandzhieva, E. E. Achkasov, D. I. Korabelnikov, D. M. Ampilogova, S. M. Khlopkova | ||
"... of Health of the Russian Federation of June 31, 2020 No. 788n “Organization of medical rehabilitation ..." | ||
Vol 16, No 4 (2023) | Comparative chemomicrobiomic analysis of bacteriocins | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova | ||
"... . Material and methods. Chemomicrobiome analysis of bacteriocins A/B, C, S, 28b, RS-2020 was performed ..." | ||
Vol 13, No 4 (2020) | Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm | Abstract similar documents |
M. Yu. Frolov, A. S. Salasyuk, V. A. Rogov | ||
"... of biological therapy, and the use of glucocorticosteroids (GC)). Data from a prospective, historical controlled ..." | ||
Vol 8, No 4 (2015) | THE COST OF NUTRITION ALTERNATIVES FOR PREMATURE INFANTS IN RUSSIA | Abstract similar documents |
K. V. Gerasimova, M. V. Avxentyeva, I. A. Belyaeva | ||
"... the clinical trials. Besides we calculated the BM cost when BM fortifier is added for low-weight infants ..." | ||
Vol 10, No 2 (2017) | COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD | Abstract similar documents |
E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov, N. L. Bondarenko, A. V. Karaulov | ||
"... expenditures. Materials and methods. We used the available information from research, clinical trials ..." | ||
Vol 11, No 2 (2018) | Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia | Abstract similar documents |
N. A. Avxentyev, M. Yu. Frolov, A. S. Makarov | ||
"... and methods. Using the clinical trial data we developed a Markov model of CML progression on nilotinib ..." | ||
Vol 11, No 3 (2018) | Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review | Abstract similar documents |
D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin | ||
"... with interferon β -1a. As evidenced by a randomized clinical trial, the annualized relapse rate estimated after 96 ..." | ||
1 - 50 of 77 Items | 1 2 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)